Friday, November 13, 2026
Translate
PrivacySubmit newsShare your story Newsletter Advertise
Breaking

Javené

HTL Biotechnology Invests €15 Million in HTL8 Polynucleotide Unit. Source: Company press releases (PR Newswire)

HTL Biotechnology Invests €15 Million in HTL8 Polynucleotide Unit

The French biotech company expanded its Javené site with a new facility dedicated to pharmaceutical-grade polynucleotides.

United StatesCompany press releases (PR Newswire)